Inventor · disambiguated record
Mao Bi
Also filed as: BI MAO
4 granted patents·3 pending applications·15 citations·filing 2017–2024
69Inventor score
Files withINNOVATIVE CELLULAR THERAPEUTICS CO LTD4INNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD2INNOVATIVE CELLULAR THERAPEUTICS INC1
Top patents by PatentIndex Score
7 records- 0195US9932405B2Use of chimeric antigen receptor modified cells to treat cancerINNOVATIVE CELLULAR THERAPEUTICS CO LTD·Filed 2017·Granted Apr 3, 2018·13 cites·8 claims
- 0288US10793638B2Use of chimeric antigen receptor modified cells to treat cancerINNOVATIVE CELLULAR THERAPEUTICS CO LTD·Filed 2018·Granted Oct 6, 2020·2 cites·15 claims
- 0382US2024218075A1Use of chimeric antigen receptor modified cells to treat cancerINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2024·Application pending·0 cites
- 0471US11932700B2Use of chimeric antigen receptor modified cells to treat cancerINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2020·Granted Mar 19, 2024·0 cites·9 claims
- 0559US10654934B2Use of chimeric antigen receptor modified cells to treat cancerINNOVATIVE CELLULAR THERAPEUTICS CO LTD·Filed 2018·Granted May 19, 2020·0 cites·33 claims
- 0651US2017218380A1Method for directional cloningINNOVATIVE CELLULAR THERAPEUTICS CO LTD·Filed 2017·Application pending·0 cites
- 0748US2022265708A1Modified Cell Expansion and Uses ThereofINNOVATIVE CELLULAR THERAPEUTICS INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mao Bi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →